Cargando…

Obesogenic and leptogenic medication utilization in people with obesity: Is there a prescription for improvement?

Detalles Bibliográficos
Autor principal:	Grunvald, Eduardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904072/ https://www.ncbi.nlm.nih.gov/pubmed/36778927 http://dx.doi.org/10.1016/j.lana.2022.100259

Ejemplares similares

Effect of Obesogenic Medications on Weight-Loss Outcomes in a Behavioral Weight-Management Program
por: Desalermos, Athanasios, et al.
Publicado: (2019)

Obesity and COVID-19: a call for action from people living with obesity
por: Le Brocq, S, et al.
Publicado: (2020)

Obesogens: An Environmental Link to Obesity
por: Holtcamp, Wendee
Publicado: (2012)

Role of Obesogens in the Pathogenesis of Obesity
por: Shahnazaryan, Urszula, et al.
Publicado: (2019)

Understanding the restrictions in the prescription and use of potentially beneficial diabetes medications associated with low socio-economic status
por: Nauck, Michael A., et al.
Publicado: (2022)

The effects of provider-prescribed obesogenic drugs on post-laparoscopic sleeve gastrectomy outcomes: A retrospective cohort study
por: Leggett, Cecilia B., et al.
Publicado: (2018)

A prescription for fair housing during the COVID-19 pandemic
por: Hussaini, Syed M Qasim
Publicado: (2021)

Research trends in obesity & obesogenic environments in Korea
por: Lee, Myoungsook
Publicado: (2019)

Antifungal management in ICU: careful follow-up of voriconazole prescription needed!
por: Reizine, Florian, et al.
Publicado: (2023)

Preventing obesity through school based approaches to improve nutrition
por: Pallan, Miranda, et al.
Publicado: (2023)

Comment: Early nutrition prescription in critically ill patients—learnings from the FRANS study
por: Berger, Mette M., et al.
Publicado: (2023)

A complex intervention to improve anxiety in people with systemic sclerosis during COVID-19
por: Newby, Jill M
Publicado: (2021)

New prescriptions for neglected diseases
por: Maskalyk, James
Publicado: (2007)

Obesogens in Foods
por: Kladnicka, Iva, et al.
Publicado: (2022)

Endocrine disruption and obesity: A current review on environmental obesogens
por: Gupta, Radhika, et al.
Publicado: (2020)

Older people: forgotten victims amid the Ukrainian humanitarian disaster
por: Armocida, Benedetta, et al.
Publicado: (2022)

Environmental Obesogens and Their Impact on Susceptibility to Obesity: New Mechanisms and Chemicals
por: Egusquiza, Riann Jenay, et al.
Publicado: (2020)

Emergence of the obesity epidemic preceding the presumed obesogenic transformation of the society
por: Pedersen, Mads Møller, et al.
Publicado: (2023)

Phentermine–topiramate extended release for the dual treatment of obesity and sleep-related eating disorder: a case report
por: Grunvald, Eduardo, et al.
Publicado: (2022)

Socioeconomic status and use of obesogenic and anti-obesity medications in the United States: A population-based study
por: Lyu, Beini, et al.
Publicado: (2022)

On the Utility of ToxCast™ and ToxPi as Methods for Identifying New Obesogens
por: Janesick, Amanda Shaine, et al.
Publicado: (2016)

The utility of accessibility clauses in resident contracts
por: Clarke, Quinten K.
Publicado: (2023)

Moving forward: embracing challenges as opportunities to improve medical education in the post-COVID era
por: Kim, Kyong-Jee
Publicado: (2022)

The reality of living with obesity
por: Brocq, Sarah Le
Publicado: (2022)

A plan for accelerated action on obesity
por: Branca, Francesco, et al.
Publicado: (2023)

My Obesogenic Personality
por: Saxena, Indu
Publicado: (2022)

COVID-19 in people with HIV
por: Xu, Zhe, et al.
Publicado: (2020)

Influenza vaccination and healthcare utilization in asthma: a Canadian experience
por: Moitra, Subhabrata, et al.
Publicado: (2023)

Carbon mineralization pathways for carbon capture, storage and utilization
por: Gadikota, Greeshma
Publicado: (2021)

COVID-19 immunisation in older people
por: Vigezzi, Giacomo Pietro, et al.
Publicado: (2022)

COVID-19 in children and young people
por: Felsenstein, Susanna, et al.
Publicado: (2020)

Is calorie labelling on menus the solution to obesity?
por: Yeo, Giles S. H.
Publicado: (2022)

Novel biomarkers of childhood and adolescent obesity
por: Yanes Cardozo, Licy L., et al.
Publicado: (2021)

Comment on “On the Utility of ToxCast™ and ToxPi as Methods for Identifying New Obesogens”
por: Houck, Keith A., et al.
Publicado: (2017)

Prevalence of Canine Obesity, Obesity-Related Metabolic Dysfunction, and Relationship with Owner Obesity in an Obesogenic Region of Spain
por: Montoya-Alonso, J. Alberto, et al.
Publicado: (2017)

Measurement of blood pressure in people with atrial fibrillation
por: Clark, Christopher E., et al.
Publicado: (2019)

COVID-19 and eating disorders in young people
por: Solmi, Francesca, et al.
Publicado: (2021)

Several areas of overlap between obesity and aging indicate obesity as a biomarker of accelerated aging of human B cell function and antibody responses
por: Frasca, Daniela
Publicado: (2022)

Will the COVID-19 pandemic worsen the obesity epidemic?
por: Clemmensen, Christoffer, et al.
Publicado: (2020)

COVID-19 severity and obesity: are MAIT cells a factor?
por: McCarthy, Cormac, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o861lvisbqheb8hk5kaespjd7b